Work and home productivity of people living with HIV in Zambia and South Africa
File(s)Work_and_home_productivity_of_people_living_with_HIV.pdf (170.26 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Objective: To compare number of days lost to illness or accessing healthcare for HIV-positive and HIV-negative individuals working in the informal and formal sectors in South Africa and Zambia.
Design: As part of the HPTN 071 (PopART) study, data on adults aged 18–44 years were gathered between in cross-sectional surveys of random general population samples in 21 communities in Zambia and South Africa. Data on the number of productive days lost in the last 3 months, laboratory-confirmed HIV status, labour force status, age, ethnicity, education, and recreational drug use was collected.
Methods: Differences in productive days lost between HIV-negative and HIV-positive individuals (“excess productive days lost”) were estimated with negative binomial models, and results disaggregated for HIV-positive individuals after various durations on Anti-retroviral treatment (ART).
Results: From samples of 19,330 respondents in Zambia and 18,004 respondents in South Africa, HIV-positive individuals lost more productive days to illness than HIV-negative individuals in both countries. HIV-positive individuals in Zambia lost 0.74 excess productive days (95%CI: 0.48–1.01; p < 0.001) to illness over a three-month period. HIV-positive in South Africa lost 0.13 excess days (95%CI: 0.04–0.23; p = 0.007). In Zambia, those on ART for less than one year lost most days, and those not on ART lost fewest days. In South Africa, results disaggregated by treatment duration were not statistically significant.
Conclusions: There is a loss of work and home productivity associated with HIV, but it is lower than existing estimates for HIV-positive formal sector workers. The findings support policy makers in building an accurate investment case for HIV interventions.
Design: As part of the HPTN 071 (PopART) study, data on adults aged 18–44 years were gathered between in cross-sectional surveys of random general population samples in 21 communities in Zambia and South Africa. Data on the number of productive days lost in the last 3 months, laboratory-confirmed HIV status, labour force status, age, ethnicity, education, and recreational drug use was collected.
Methods: Differences in productive days lost between HIV-negative and HIV-positive individuals (“excess productive days lost”) were estimated with negative binomial models, and results disaggregated for HIV-positive individuals after various durations on Anti-retroviral treatment (ART).
Results: From samples of 19,330 respondents in Zambia and 18,004 respondents in South Africa, HIV-positive individuals lost more productive days to illness than HIV-negative individuals in both countries. HIV-positive individuals in Zambia lost 0.74 excess productive days (95%CI: 0.48–1.01; p < 0.001) to illness over a three-month period. HIV-positive in South Africa lost 0.13 excess days (95%CI: 0.04–0.23; p = 0.007). In Zambia, those on ART for less than one year lost most days, and those not on ART lost fewest days. In South Africa, results disaggregated by treatment duration were not statistically significant.
Conclusions: There is a loss of work and home productivity associated with HIV, but it is lower than existing estimates for HIV-positive formal sector workers. The findings support policy makers in building an accurate investment case for HIV interventions.
Date Issued
2019-05-01
Date Acceptance
2018-12-17
Citation
AIDS, 2019, 33 (6), pp.1063-1071
ISSN
0269-9370
Publisher
Lippincott, Williams & Wilkins
Start Page
1063
End Page
1071
Journal / Book Title
AIDS
Volume
33
Issue
6
Copyright Statement
Q 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the
Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Sponsor
National Institute for Health Research
Pepfar, NIAID, NIMH, NIDA, BMGF
Medical Research Council (MRC)
Imperial College Healthcare NHS Trust- BRC Funding
National Institutes of Health
National Institutes of Health
Medical Research Council (MRC)
National Institutes of Health
National Institutes of Health
Department for International Development (UK) (DFI
Imperial College Healthcare NHS Trust- BRC Funding
Grant Number
HPRU-2012-10080
MR/R015600/1
RDA02 79560
UM1AI068619
EPIDVH72
MR/L00528X/1
HPTN071 Substudy:Phylo PopART
PO15001410 (UMIAI068619)
N/A
RDA02
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
Virology
absenteeism
economics
HIV/AIDS
informal sector
labour productivity
sickness days
ANTIRETROVIRAL THERAPY
LABOR PRODUCTIVITY
IMPACT
ABSENTEEISM
PERFORMANCE
INITIATION
COHORT
COUNT
AIDS
HPTN 071 (PopART) Study Team
06 Biological Sciences
11 Medical and Health Sciences
17 Psychology and Cognitive Sciences
Virology
Publication Status
Published
Date Publish Online
2019-01-31